Vaibhav Agrawal

Assistant Professor

City Of Hope National Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vaibhav Agrawal is an Assistant Professor at the City Of Hope National Medical Center in the United States. His research primarily focuses on advancements in CAR-T cell therapy, targeted therapies for acute lymphoblastic leukemia, and management of complications following hematopoietic stem cell transplantation. Recent publications include studies on tocilizumab for cytokine release syndrome and the efficacy of CD19-targeted therapies in relapsed B-ALL.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Gulrayz Ahmed

Assistant Professor

Medical College of Wisconsin

UNITED STATES

View details

Rajshekhar Chakraborty

Assistant Professor of Medicine

Columbia University Irving Medical Center

UNITED STATES

View details

Amer Assal

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Olle Ringden

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vaibhav Agrawal

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia

Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab

The feasibility of additional CD19‐targeted cellular therapy in relapsed/refractory B‐ALL with re‐emergence of CD19 antigen after prior CD19‐negative relapse

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia

Collaborators (4)

Gulrayz Ahmed

Rajshekhar Chakraborty

Amer Assal

Olle Ringden

Make your next move.